We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2006 by Hadassah Medical Organization.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00317668
First Posted: April 25, 2006
Last Update Posted: May 1, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hadassah Medical Organization
  Purpose
The investigators will check the serum of epilepsy patients for antibodies against glutamate receptors and double stranded DNA. They will characterise the patients (by the kind of epilepsy, autoimmune disease comorbidity, and cognitive profile).

Condition
Epilepsy

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 250
Study Start Date: November 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 120 epilepsy patients from the epilepsy clinic and Emergency Room (ER)
  • Controls: 100 patients with other neurological diseases and no epilepsy; and 30 healthy volunteers.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00317668


Contacts
Contact: Dana Ekstein, MD dekstein@md.huji.ac.il

Locations
Israel
Hadassah Ein-Kerem Medical Center Recruiting
Jerusalem, Israel
Principal Investigator: Dana Ekstein, MD         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Dana Ekstein, MD Hadassah Medical Organization
  More Information

ClinicalTrials.gov Identifier: NCT00317668     History of Changes
Other Study ID Numbers: autoimmunepi-HMO-CTIL
First Submitted: April 23, 2006
First Posted: April 25, 2006
Last Update Posted: May 1, 2007
Last Verified: April 2006

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases